TradeTech Eye — Capital Markets Technology News

Leerink Partners Appoints Chris McCarthy as Senior Managing Director to Bolster Healthcare Equities

By Lauren Towner · 24 August 2026

In brief: Leerink Partners has hired Chris McCarthy, a top-ranked RBC Capital Markets veteran, as Senior Managing Director to expand its healthcare sales and institutional equities capabilities in New York.

Key facts
New HireChris McCarthy
RoleSenior Managing Director
Experience25+ years
Office LocationNew York
Press Release: Leerink Partners Appoints Chris McCarthy as Senior Managing Director to Bolster Healthcare Equities | Featured Image by FF News

Quick Summary

Leerink Partners has appointed Chris McCarthy as Senior Managing Director to enhance its healthcare investment banking and institutional equities platform. McCarthy, a top-ranked sales professional formerly at RBC Capital Markets, will leverage 25 years of expertise to provide differentiated market insights for institutional investors in the New York office.

How Does Chris McCarthy Strengthen Leerink Partners?

The addition of Chris McCarthy brings unparalleled sales leadership to the firm's New York operations. With over 25 years of experience, McCarthy is recognized as a premier figure in the sector, having been ranked the No. 1 Healthcare Salesperson by Institutional Investor three times in the last five years. His arrival signals a significant boost to the firm's healthcare sales capabilities and its ability to service complex institutional needs.

  • 25+ years of institutional healthcare experience.
  • Top-tier rankings from Institutional Investor.
  • Strategic collaboration across research, trading, and capital markets.

What Value Does This Bring to Institutional Investors?

Institutional investors gain access to deep market intelligence and a professional who has built trusted industry relationships over decades. McCarthy’s role involves delivering strategic advice to help clients navigate the rapidly evolving healthcare landscape. By integrating his expertise with Leerink’s existing institutional equities platform, the firm ensures that clients receive the high-level focus required for modern healthcare investing.

FF NEWS TAKE:

The recruitment of a top-ranked veteran like Chris McCarthy is a clear signal that the healthcare investment banking sector remains a high-stakes battleground for talent. As market volatility persists, institutional investors are increasingly demanding specialized sector expertise over generalist coverage. This move highlights a broader trend where boutique and specialized firms are aggressively scaling their equities platforms to capture market share from larger, diversified investment banks.

Frequently asked questions

Who is the new Senior Managing Director at Leerink Partners?

Chris McCarthy has joined Leerink Partners as Senior Managing Director. He brings over 25 years of experience in healthcare sales and was previously the No. 1 ranked salesperson at RBC Capital Markets.

What is Chris McCarthy's background in healthcare sales?

McCarthy has over 25 years of experience serving institutional healthcare investors. Before joining Leerink Partners, he held senior roles at RBC Capital Markets, Bank of America, and Cowen (now TD Cowen).

How will this appointment affect Leerink Partners' equities platform?

The appointment is designed to strengthen Leerink Partners' Institutional Equities platform and expand its healthcare sales capabilities. McCarthy will provide differentiated market insights and strategic advice to institutional investors.

About the companies

Bank of America

Website · 110 stories and 13 video interviews on FF News since 2019

Previously on FF News:

Leerink Partners

Website · 1 story on FF News since 2026

TD Cowen

4 stories on FF News since 2026

Previously on FF News:

Companies in this story: Bank of America, Leerink Partners, TD Cowen, RBC Capital Markets, Institutional Investor

People in this story: Rob Leerink, Chris McCarthy

More from News